Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib vs Gemcitabine/Carboplatin in Advanced NSCLC
NCT00264498Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung carcinoma (NSCLC), sponsored by AstraZeneca. Started Oct 2004; status: completed.
02
Drugs
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT00264498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264498.